Robyn Jane Macfarlane
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
-
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
Papers in
-
- Prostate Cancer Treatment and Research 6
- Renal cell carcinoma treatment 6
-
- Cancer Genomics and Diagnostics 7
- Cancer, Lipids, and Metabolism 2
- MicroRNA in disease regulation 2
- Cancer-related molecular mechanisms research 2
- Co-authors
- Kim N. (8 shared papers)Wayne D. Tilley (1 shared paper)Scott L. Townley (1 shared paper)Joanna L. Gillis (1 shared paper)Lisa M. Butler (1 shared paper)Villis R. Marshall (1 shared paper)Krisna Murti (1 shared paper)Luke A. Selth (1 shared paper)
- Journals
- Journal of Clinical Oncology (10 papers)Expert Opinion on Drug Safety (1 paper)Urologic Clinics of North America (1 paper)European Journal of Cancer (1 paper)Otolaryngology (1 paper)
- Partner nations
- CanadaUnited StatesFinland
In The Last Decade
Robyn Jane Macfarlane
20 papers receiving 421 citations
Peers
Comparison fields: 5 of 48
- Cancer Research 266
- Pulmonary and Respiratory Medicine 127
- Molecular Biology 236
- Oncology 56
- Genetics 8
Countries citing papers authored by Robyn Jane Macfarlane
This map shows the geographic impact of Robyn Jane Macfarlane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robyn Jane Macfarlane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robyn Jane Macfarlane more than expected).
Fields of papers citing papers by Robyn Jane Macfarlane
This network shows the impact of papers produced by Robyn Jane Macfarlane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robyn Jane Macfarlane. The network helps show where Robyn Jane Macfarlane may publish in the future.
Co-authors
The 25 scholars most cited alongside Robyn Jane Macfarlane, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 156 | |
| 2 | 2013 | 102 | |
| 3 | 2012 | 32 | |
| 4 | 2019 | 24 | |
| 5 | 2010 | 23 | |
| 6 | 2011 | 22 | |
| 7 | 2010 | 17 | |
| 8 | 2020 | 11 | |
| 9 | 2010 | 7 | |
| 10 | 2013 | 6 | |
| 11 | 2023 | 5 | |
| 12 | 2013 | 5 | |
| 13 | 2024 | 5 | |
| 14 | 2017 | 4 | |
| 15 | 2015 | 4 | |
| 16 | 2015 | 3 | |
| 17 | 2015 | 2 | |
| 18 | 2025 | 1 | |
| 19 | 2024 | 1 | |
| 20 | 2023 | 1 |
About Robyn Jane Macfarlane
Robyn Jane Macfarlane is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research, Oncology, Molecular Biology and Economics and Econometrics, having authored 22 papers that have together received 431 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (7 papers), Prostate Cancer Treatment and Research (6 papers), Renal cell carcinoma treatment (6 papers), Cancer, Lipids, and Metabolism (2 papers), Circular RNAs in diseases (2 papers), MicroRNA in disease regulation (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Cancer Research (266 citations), Pulmonary and Respiratory Medicine (127 citations), Molecular Biology (236 citations), Oncology (56 citations) and Genetics (8 citations). Robyn Jane Macfarlane has collaborated with scholars based in Canada, United States and Finland. Frequent co-authors include Kim N., Wayne D. Tilley, Scott L. Townley, Joanna L. Gillis, Lisa M. Butler, Villis R. Marshall, Krisna Murti, Luke A. Selth, Martin Gleave and Akira Watahiki. Their work appears in journals such as Journal of Clinical Oncology, Expert Opinion on Drug Safety, Urologic Clinics of North America, European Journal of Cancer and Otolaryngology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.